EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lonidamine, a Novel Modulator for the BvgAS System of Bordetella Species

Natsuko Ota, Takashi Nishida, Daron M Standley, Aalaa Alrahman Sherif, Satoshi Iwano, Dendi Krisna Nugraha, Toshiya Ueno, Yasuhiko Horiguchi

Microbiology and Immunology · 2025-03 · 69 (3) · 133-147

DOI: 10.1111/1348-0421.13193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology and Immunology, online erschienen am 15.12.2024. Verfasst von Natsuko Ota und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Bacteriology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan. Hauptthemen laut MEDLINE: Bacterial Proteins, Bordetella, Transcription Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was supported by JSPS KAKENHI (Grant Numbers; 23K27408, 23H02717, and 21K19378), JST SPRING (Grant Number JPMJSP2138), The Nippon Foundation-Osak….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Gram‐negative bacteria Bordetella pertussis , B. parapertussis , and B. bronchiseptica cause respiratory diseases in various mammals. They share the BvgAS two‐component system, which regulates the phenotypic conversion between the virulent Bvg + and avirulent Bvg – phases. In the BvgAS system, the sensor kinase BvgS senses environmental cues and transduces a phosphorelay signal to the response regulator BvgA, which leads to the expression of Bvg + phase‐specific genes, including virulence factor genes. Bacteria grown at 37°C exhibit the Bvg + phenotype. In contrast, at lower than 26°C or in the presence of modulators, such as MgSO 4 and nicotinic acid, the BvgAS system is inactivated, leading bacteria to the avirulent Bvg – phase. Therefore, effective modulators are expected to provide a therapeutic measure for Bordetella infection; however, no such modulators are currently available, and the mechanism by which modulators inactivate the BvgAS system is poorly understood. In the present study, we identified lonidamine as a novel modulator after screening an FDA‐approved drug library using bacterial reporter systems with the Bvg + ‐specific and Bvg – ‐specific promoters. Lonidamine directly bound to the VFT2 domain of BvgS and inactivated the BvgAS system at concentrations as low as 50 nM, which was at least 2000‐ to 20,000‐fold lower than the effective concentrations of known modulators. Lonidamine significantly reduced the adherence of B. pertussis to cultured cells but unexpectedly exacerbated bacterial colonization of the mouse nasal septum. These results provide insights into the structural requirements for BvgAS modulators and the role of Bvg phenotypes in the establishment of infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacterial ProteinsBordetellaTranscription FactorsAnimalsGene Expression Regulation, BacterialBordetella InfectionsMiceBordetella bronchisepticaVirulence FactorsVirulenceBordetella pertussisSignal TransductionBordetella parapertussis

Stichwörter der Autor:innen

BordetellaBvgASlonidaminemodulatorphase conversion

Substanzen

Bacterial ProteinsBvgA protein, BacteriaTranscription FactorsVirulence FactorsbvgS protein, Bordetella pertussis

Autor:innen und Institutionen

  • Department of Molecular Bacteriology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Department of Genome Informatics, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Immunology Frontier Research Center, Osaka University, Suita, Japan.
  • Center for Infectious Disease Education and Research, Osaka University, Suita, Japan.
  • Institute for Tenure Track Promotion, University of Miyazaki, Miyazaki, Japan.

Förderung

  • This research was supported by JSPS KAKENHI (Grant Numbers; 23K27408, 23H02717, and 21K19378), JST SPRING (Grant Number JPMJSP2138), The Nippon Foundation-Osak…

Zitieren

APA

Ota, N., Nishida, T., Standley, D. M., Sherif, A. A., Iwano, S., Nugraha, D. K., Ueno, T., & Horiguchi, Y. (2025). Lonidamine, a Novel Modulator for the BvgAS System of Bordetella Species. Microbiology and Immunology, 69(3), 133-147. https://doi.org/10.1111/1348-0421.13193

Vancouver

Ota N, Nishida T, Standley DM, Sherif AA, Iwano S, Nugraha DK, et al. Lonidamine, a Novel Modulator for the BvgAS System of Bordetella Species. Microbiology and Immunology. 2025;69(3):133-147. doi:10.1111/1348-0421.13193

BibTeX
@article{Ota2025,
  author = {Ota, Natsuko and Nishida, Takashi and Standley, Daron M and Sherif, Aalaa Alrahman and Iwano, Satoshi and Nugraha, Dendi Krisna and Ueno, Toshiya and Horiguchi, Yasuhiko},
  title = {Lonidamine, a Novel Modulator for the BvgAS System of Bordetella Species},
  journal = {Microbiology and Immunology},
  year = {2025},
  volume = {69},
  number = {3},
  pages = {133--147},
  doi = {10.1111/1348-0421.13193}
}
Kostenlos starten →